Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Enterprise Value (2022 - 2026)

HeartSciences' Enterprise Value history spans 5 years, with the latest figure at -$3.4 million for Q1 2026.

  • For Q1 2026, Enterprise Value fell 30.83% year-over-year to -$3.4 million; the TTM value through Jan 2026 reached -$3.4 million, down 30.83%, while the annual FY2025 figure was -$1.1 million, 81.07% up from the prior year.
  • Enterprise Value reached -$3.4 million in Q1 2026 per HSCS's latest filing, down from -$2.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$100144.0 in Q4 2023 to a low of -$7.1 million in Q1 2024.
  • Average Enterprise Value over 5 years is -$2.9 million, with a median of -$2.7 million recorded in 2025.
  • Peak YoY movement for Enterprise Value: surged 96.74% in 2023, then crashed 3946.29% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$3.1 million in 2022, then soared by 96.74% to -$100144.0 in 2023, then plummeted by 3946.29% to -$4.1 million in 2024, then soared by 51.85% to -$2.0 million in 2025, then crashed by 74.11% to -$3.4 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Enterprise Value are -$3.4 million (Q1 2026), -$2.0 million (Q4 2025), and -$2.8 million (Q3 2025).